Correlation of Brain Natriuretic Peptide and Microalbuminuria in Patients with Heart Failure

被引：0

作者：

Peng, T. ^{[1
]}

Gao, H. ^{[2
]}

Shen, L. ^{[2
]}

Xu, F. ^{[3
]}

Yang, X. ^{[1
]}

机构：

[1] Shandong Univ, Qilu Hosp, Dept Nephrol, Jinan 250012, Peoples R China

[2] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan 250012, Peoples R China

[3] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250012, Peoples R China

来源：

WEST INDIAN MEDICAL JOURNAL | 2011年 / 60卷 / 06期

关键词：

Heart failure; microalbuminuria; N-terminal pro-brain natriuretic pepide; ALBUMINURIA; PREVALENCE; DISEASE; RISK;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To evaluate the changes of plasma levels of N-terminal pro-brain natriuretic pepide (NT-proBNP) and microalbuminuria (MA U) in patients with heart failure and the correlation between them. Methods: Ninety-one patients with heart failure were divided into different groups according to different stages of heart failure. Plasma levels of NT-proBNP were measured by microsome enzyme immunoassay (MEIA). Plasma levels of MAU were determined by immune scattering turbidimetry (ICTM). Simultaneously, left ventricular ejection fraction (LVEF) and left ventricular end diastolic diameter (LVEDD) were measured by Doppler echocardiography for all patients. The correlation of NT-proBNP and MAU was evaluated at different stages of heart failure. Results: The plasma levels of NT-proBNP and MAU increased with the severity of heart failure. There was a high correlation between NT-proBNP and MAU (r = 0.885, p < 0.001). Conclusion: Both NT-proBNP and MAU levels were closely associated with the severity of heart failure.

引用

页码：658 / 661

页数：4

共 18 条

[1] Usefulness of Microalbuminuria in Patients With the Metabolic Syndrome to Predict Subclinical Atherosclerosis and Cardiovascular Disease Outcomes
Afonso, Luis
Hari, Pawan
Kondur, Ashok
Veeranna, Vikas
Manickam, Palaniappan
Simegn, Mengistu
Jacob, Sony
Ference, Brian
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07) : 976 - 983
[2] Albuminuria: An indicator of cardiovascular risk
Bramlage, Peter
Thoenes, Martin
Paar, W. Dieter
Bramlage, Carsten P.
Schmieder, Roland E.
[J]. MEDIZINISCHE KLINIK, 2007, 102 (10) : 833 - 843
[3] Chinese Society of Cardiology of Chinese Medical Association, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1076
[4] DEVEREUX RB, 1987, HYPERTENSION, V9, P53
[5] ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
Dickstein, Kenneth
Cohen-Solal, Alain
Filippatos, Gerasimos
McMurray, John J. V.
Ponikowski, Piotr
Poole-Wilson, Philip Alexander
Stromberg, Anna
van Veldhuisen, Dirk J.
Atar, Dan
Hoes, Arno W.
Keren, Andre
Mebazaa, Alexandre
Nieminen, Markku
Priori, Silvia Giuliana
Swedberg, Karl
[J]. EUROPEAN HEART JOURNAL, 2008, 29 (19) : 2388 - 2442
[6] Albuminuria in heart failure: what do we really know?
Dobre, Daniela
Nimade, Sandeep
de Zeeuw, Dick
[J]. CURRENT OPINION IN CARDIOLOGY, 2009, 24 (02) : 148 - 154
[7] Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea
Fabbian, Fabio
De Giorgi, Alfredo
Pala, Marco
Tiseo, Ruana
Portaluppi, Francesco
[J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (01) : 108 - 111
[8] Ho Chao-Chung, 2009, Hu Li Za Zhi, V56, P16
[9] Albuminuria in chronic heart failure: prevalence and prognostic importance
Jackson, Colette E.
Solomon, Scott D.
Gerstein, Hertzel C.
Zetterstrand, Sofia
Olofsson, Bertil
Michelson, Eric L.
Granger, Christopher B.
Swedberg, Karl
Pfeffer, Marc A.
Yusuf, Salim
McMurray, John J. V.
[J]. LANCET, 2009, 374 (9689) : 543 - 550
[10] The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
Januzzi, JL
Camargo, CA
Anwaruddin, S
Baggish, AL
Chen, AA
Krauser, DG
Tung, R
Cameron, R
Nagurney, JT
Chae, CU
Lloyd-Jones, DM
Brown, DF
Foran-Melanson, S
Sluss, PM
Lee-Lewandrowski, EL
Lewandrowski, KB
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (08) : 948 - 954

← 1 2 →